176 extractive question-and-answer pairs built from Vol III, published by icmr.gov.in. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 47 of the 176 pairs (26.7%) are explanatory questions and 129 restate a figure. 100.00% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/international-collaborative-research-vol-iii-question-and-answer-dataset/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("international-collaborative-research-vol-iii-question-and-answer-dataset")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Consensus Document on Management of Pancreatic Cancer - Question and Answer Dataset
Economy · 268 rows
ICMR Standard Treatment Workflow for Cataract - Question and Answer Dataset
Economy · 27 rows
Neurology Questions from P a R T N E R S - Question and Answer Dataset
Economy · 107 rows
Beginner's Guide for Systematic Reviews - Question and Answer Dataset
Economy · 407 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 10 of 176 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What is the role of international cooperation in medical and health research? | ͚ sĐieŶĐe diploŵaĐy͛ , which helps in bringing nations together, whatever their differences in culture, politics or wealth may be | These projects address a wide range of research areas, including disease prevention, maternal and child health, environmental and occupational health, vaccine development as well as emerging and re-emerging infectious diseases. The international cooperation in medical and health research works as ͚ sĐieŶĐe diploŵaĐy͛ , which helps in bringing nations together, whatever their differences in culture, politics or wealth may be. The MoUs and Joint Statements covering various areas support joint research between nations to share the benefits with the communities through joint efforts. I congratulate the International Health Division of ICMR for bringing out volume III, which reaffirms it͛ s efforts towards strengthening scientific collaboration and internationalization of collaborative research. (Soumya Swaminathan) | 298 | definition | 1.000 | The international cooperation in medical and health research works as ͚ sĐieŶĐe diploŵaĐy͛ , which helps in bringing nations together, whatever their differences in culture, politics or wealth may be. | 3 | page=3,block=1 | 0.700 | valid |
| What was the main topic of the SAFHeR Foundation Workshop held from 9-12 February, 2015? | Clinical and Laboratory Medicine Research | Indian Council of Medical Research 28 Professor Vladislav Ya PANCHENKO, Chairman of RBFR & Dr. Alexander N. Sharov attended discussion meeting on implementation plan of ICMR-RFBR MoU on 12th December, 2014 at ICMR Headquarters in New Delhi SAFHeR :Foundation Workshop for Under- Graduate Medical students on Clinical and Laboratory Medicine Research during 9-12 February, 2015 at National Institute of Pathology (NIP) in New Delhi | 308 | definition | 1.000 | Sharov attended discussion meeting on implementation plan of ICMR-RFBR MoU on 12th December, 2014 at ICMR Headquarters in New Delhi SAFHeR :Foundation Workshop for Under- Graduate Medical students on Clinical and Laboratory Medicine Research during 9-12 February, 2015 at National Institute of Pathology (NIP) in New Delhi | 33 | page=33,block=0 | 0.700 | valid |
| What is the purpose of the m-CTG device being developed under the project led by Dr. Manoja Kumar Das? | antenatal and intrapartum monitoring to prevent perinatal mortality in low resource settings | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area m-CTG: A low cost mobile phone cardiotocograph device for antenatal and intrapartum monitoring to prevent perinatal mortality in low resource settings Dr. Manoja Kumar Das Director The INCLEN Trust International & CHNRI, F-1/5, 2nd Floor, Okhla Industrial Area, Phase 1, New Delhi-110020 Grand Challenges (GC), Canada | 143 | definition | 1.000 | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area m-CTG: A low cost mobile phone cardiotocograph device for antenatal and intrapartum monitoring to prevent perinatal mortality in low resource settings Dr. | 54 | page=54,block=34 | 0.700 | valid |
| What is the full form of the acronym 'TB APPRISE'? | TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area P1078 TB APPRISE, A phase IV randomized double – blind placebo controlled trial to evaluate the safety of immediate (antepartum initiated) versus deferred (postpartum initiated) isoniazid preventive therapy among HIV infected women in high TB incidence settings, “TB APPRISE” stands for TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants. Dr. Ramesh Bhosale Professor & Head B J Medical College and Sassoon General Hospital, Jai Prakash Narayan Road, Pune-411001 National Institutes of Health (NIH), USA | 372 | definition | 1.000 | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area P1078 TB APPRISE, A phase IV randomized double – blind placebo controlled trial to evaluate the safety of immediate (antepartum initiated) versus deferred (postpartum initiated) isoniazid preventive therapy among HIV infected women in high TB incidence settings, “TB APPRISE” stands for TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants. | 71 | |||
| What is the complete title of the ACTG 5288 project? | Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE) | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area ACTG 5288 Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE) Dr. M Ghate National AIDS Research Institute (NARI), G-73 Bhosari Industial Estate, Bhosari, Pune-411026 Dr. N. Kumarasamy, Y R Gaitonde Centre for AIDS Research and Education (YRG CARE), Voluntary Health Services, Taramani, Chennai- 600113 & Dr. Ajay Chandanwale, B J Medical College and Sassoon General Hospital, Jai Prakash Narayan Road, Pune-411001 National Institutes of Health (NIH), USA | 95 | definition | 1.000 | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area ACTG 5288 Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE) Dr. | 72 | page=72,block=3 | 0.700 | valid |
| What type of therapy is being evaluated in the INTERTECC clinical trial? | intensity modulated radiation therapy with concurrent cisplatin | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area International Evaluation of Radiotherapy Technology Effectiveness in Cervical Cancer (INTERTECC): Phase II/III clinical trial of intensity modulated radiation therapy with concurrent cisplatin for stage I-IV A cervical carcinoma Dr. Umesh Mahantshetty Associate Professor Tata Memorial Hospital,Tata Memorial Centre, Parel, Mumbai- 400012 National Institutes of Health (NIH), USA | 214 | definition | 1.000 | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area International Evaluation of Radiotherapy Technology Effectiveness in Cervical Cancer (INTERTECC): Phase II/III clinical trial of intensity modulated radiation therapy with concurrent cisplatin for stage I-IV A cervical carcinoma Dr. | 72 | page=72,block=34 | 0.700 | valid |
| What is the purpose of the laboratory being established by Dr. Anup Anvikar? | quality assurance of malaria RDTs | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area Establishment of a WHO – recognized laboratory for quality assurance of malaria RDTs Dr. Anup Anvikar Scientist D National Institute of Malaria Research(NIMR), Sector-8, Dwarka, New Delhi-110077 The Global Fund for AIDS, Tuberculosis and Malaria, USA through the National Vector Borne Disease Control Programme (NVBDCP), GoI | 136 | definition | 1.000 | Principal Investigator Funded by Date of approval Total Budget Duration Subject Area Establishment of a WHO – recognized laboratory for quality assurance of malaria RDTs Dr. | 87 | page=87,block=36 | 0.700 | valid |
| Which organization is linked to the International Health Division (IHD)? | Indian Council of Medical Research, New Delhi | An Overview of International Collaborative Health Research Projects approved by Health MiŶistry’s ScreeŶiŶg Coŵŵittee during January, 2013 to June, 2015 (Volume III) International Health Division (IHD) Indian Council of Medical Research, New Delhi | 202 | relationship | 0.970 | An Overview of International Collaborative Health Research Projects approved by Health MiŶistry’s ScreeŶiŶg Coŵŵittee during January, 2013 to June, 2015 (Volume III) International Health Division (IHD) Indian Council of Medical Research, New Delhi | 1 | page=1,block=2 | 0.700 | valid |
| What is the role of Caritas India in the IMCP-II programme? | the civil society partner supporting the IMCP-II programme of NVBDCP | Rs 24,06,800 The funding agency will route the funding through Caritas India, which is the civil society partner supporting the IMCP-II programme of NVBDCP directly approved by HMSC on 9th December, 2013 June 06, 2013 Indian Council of Medical Research 82 | 87 | relationship | 0.970 | Rs 24,06,800 The funding agency will route the funding through Caritas India, which is the civil society partner supporting the IMCP-II programme of NVBDCP directly approved by HMSC on 9th December, 2013 June 06, 2013 Indian Council of Medical Research 82 | 87 | page=87,block=47 | 0.700 | valid |
| What is the significance of the collaborative health research projects described in the document? | importance in the area of public health in India and other countries | These volumes enlist the collaborative projects undertaken by the researchers in India in prioritized key areas of health research involving foreign assistance/collaboration. The collaborative health research projects described in this document have importance in the area of public health in India and other countries. | 250 | summary | 0.970 | The collaborative health research projects described in this document have importance in the area of public health in India and other countries. | 3 | page=3,block=1 | 0.700 | valid |
Read straight from the file — download or use the API URL for the full dataset.
| page=71,block=34 |
| 0.700 |
| valid |